SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Aclaris Therapeutics, Inc. (ACRS)

ACRS RSS Feed
Add ACRS Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 9/6/2016 11:44:47 AM - Followers: 1 - Board type: Free - Posts Today: 0
Aclaris Therapeutics, Inc.

101 Lindenwood Drive
Suite 400
Malvern, PA 19355
United States
484-324-7933

http://www.aclaristx.com

Aclaris Therapeutics, Inc., a clinical-stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical drugs to address various needs in dermatology. Its lead drug candidate is A-101, a hydrogen peroxide topical solution that has completed three Phase II clinical trials for the treatment of seborrheic keratosis (SK), a common non-malignant skin tumor. The company is also developing A-101 as a prescription treatment for common warts; and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts. Aclaris Therapeutics, Inc. was founded in 2012 and is headquartered in Malvern, Pennsylvania.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ACRS
Current Price
Volume:
Bid Ask Day's Range
SureTrader
ACRS News: Aclaris Therapeutics Initiates Phase 1 Clinical Trial for ATI-50001, an Investigational JAK Inhibitor, for the Treatment of A... 12/07/2016 08:00:00 AM
ACRS News: Notice of Effectiveness (effect) 12/02/2016 06:01:43 AM
ACRS News: Post-effective Amendment to Registration Statement (pos Am) 11/28/2016 04:17:13 PM
ACRS News: Aclaris Therapeutics to Attend Upcoming Investor Conferences 11/22/2016 08:00:00 AM
ACRS News: Amended Statement of Beneficial Ownership (sc 13d/a) 11/21/2016 05:29:28 PM
PostSubject
#1   ACRS bullish 22.07 stocktrademan 09/06/16 11:44:47 AM
PostSubject